Allianz Asset Management GmbH trimmed its holdings in shares of Dentsply Sirona (NASDAQ:XRAY) by 27.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 78,600 shares of the medical instruments supplier’s stock after selling 29,861 shares during the period. Allianz Asset Management GmbH’s holdings in Dentsply Sirona were worth $5,174,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the stock. Janney Montgomery Scott LLC increased its position in shares of Dentsply Sirona by 2.0% during the third quarter. Janney Montgomery Scott LLC now owns 41,335 shares of the medical instruments supplier’s stock valued at $2,472,000 after buying an additional 830 shares during the period. BB&T Corp boosted its stake in Dentsply Sirona by 5.9% in the fourth quarter. BB&T Corp now owns 15,528 shares of the medical instruments supplier’s stock worth $1,022,000 after buying an additional 866 shares in the last quarter. Security National Bank of Sioux City Iowa IA boosted its stake in Dentsply Sirona by 3.9% in the third quarter. Security National Bank of Sioux City Iowa IA now owns 23,990 shares of the medical instruments supplier’s stock worth $1,435,000 after buying an additional 909 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its stake in Dentsply Sirona by 4.4% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 23,608 shares of the medical instruments supplier’s stock worth $1,418,000 after buying an additional 1,000 shares in the last quarter. Finally, Suntrust Banks Inc. boosted its stake in Dentsply Sirona by 15.2% in the fourth quarter. Suntrust Banks Inc. now owns 7,727 shares of the medical instruments supplier’s stock worth $507,000 after buying an additional 1,021 shares in the last quarter. Institutional investors and hedge funds own 97.79% of the company’s stock.
NASDAQ:XRAY traded down $1.07 on Friday, hitting $49.02. The stock had a trading volume of 2,452,999 shares, compared to its average volume of 2,355,784. The stock has a market capitalization of $11,145.58, a price-to-earnings ratio of 18.43, a PEG ratio of 2.14 and a beta of 1.26. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.45 and a current ratio of 2.10. Dentsply Sirona has a 52-week low of $48.25 and a 52-week high of $68.98.
Dentsply Sirona (NASDAQ:XRAY) last announced its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.01. The business had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Dentsply Sirona had a positive return on equity of 8.35% and a negative net margin of 39.39%. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period last year, the firm posted $0.67 earnings per share. equities analysts forecast that Dentsply Sirona will post 2.74 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Shareholders of record on Thursday, March 29th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.35 annualized dividend and a yield of 0.71%. Dentsply Sirona’s payout ratio is 13.16%.
In other Dentsply Sirona news, Director Eric Brandt sold 6,409 shares of the firm’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $68.04, for a total value of $436,068.36. Following the transaction, the director now directly owns 12,073 shares of the company’s stock, valued at $821,446.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.99% of the company’s stock.
Several brokerages have issued reports on XRAY. Zacks Investment Research lowered Dentsply Sirona from a “hold” rating to a “sell” rating in a research note on Monday, January 8th. Credit Suisse Group downgraded Dentsply Sirona to a “hold” rating and set a $73.00 price objective for the company. in a research report on Friday, January 5th. JPMorgan Chase upgraded Dentsply Sirona from a “neutral” rating to an “overweight” rating and set a $75.00 price objective for the company in a research report on Wednesday, December 13th. HC Wainwright reiterated a “hold” rating and issued a $68.00 price objective on shares of Dentsply Sirona in a research report on Thursday, January 18th. Finally, BidaskClub downgraded Dentsply Sirona from a “hold” rating to a “sell” rating in a report on Tuesday, January 23rd. Three analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $67.36.
COPYRIGHT VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/04/08/allianz-asset-management-gmbh-lowers-stake-in-dentsply-sirona-inc-xray.html.
About Dentsply Sirona
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Receive News & Ratings for Dentsply Sirona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply Sirona and related companies with MarketBeat.com's FREE daily email newsletter.